317 related articles for article (PubMed ID: 34751584)
1. Endogenous Opioid Dynorphin Is a Potential Link between Traumatic Brain Injury, Chronic Pain, and Substance Use Disorder.
Best KM; Mojena MM; Barr GA; Schmidt HD; Cohen AS
J Neurotrauma; 2022 Jan; 39(1-2):1-19. PubMed ID: 34751584
[TBL] [Abstract][Full Text] [Related]
2. A review of the kappa opioid receptor system in opioid use.
Cayir S; Zhornitsky S; Barzegary A; Sotomayor-Carreño E; Sarfo-Ansah W; Funaro MC; Matuskey D; Angarita G
Neurosci Biobehav Rev; 2024 Jul; 162():105713. PubMed ID: 38733895
[TBL] [Abstract][Full Text] [Related]
3. Chronic pain recruits hypothalamic dynorphin/kappa opioid receptor signalling to promote wakefulness and vigilance.
Ito H; Navratilova E; Vagnerova B; Watanabe M; Kopruszinski C; Moreira de Souza LH; Yue X; Ikegami D; Moutal A; Patwardhan A; Khanna R; Yamazaki M; Guerrero M; Rosen H; Roberts E; Neugebauer V; Dodick DW; Porreca F
Brain; 2023 Mar; 146(3):1186-1199. PubMed ID: 35485490
[TBL] [Abstract][Full Text] [Related]
4. Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction.
Karkhanis A; Holleran KM; Jones SR
Int Rev Neurobiol; 2017; 136():53-88. PubMed ID: 29056156
[TBL] [Abstract][Full Text] [Related]
5. Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System.
Leconte C; Mongeau R; Noble F
Front Pharmacol; 2022; 13():856672. PubMed ID: 35571111
[TBL] [Abstract][Full Text] [Related]
6. Release of endogenous dynorphin opioids in the prefrontal cortex disrupts cognition.
Abraham AD; Casello SM; Schattauer SS; Wong BA; Mizuno GO; Mahe K; Tian L; Land BB; Chavkin C
Neuropsychopharmacology; 2021 Dec; 46(13):2330-2339. PubMed ID: 34545197
[TBL] [Abstract][Full Text] [Related]
7. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.
Zhou L; Stahl EL; Lovell KM; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
Neuropharmacology; 2015 Dec; 99():131-41. PubMed ID: 26160155
[TBL] [Abstract][Full Text] [Related]
8. The dynorphin/kappa opioid receptor mediates adverse immunological and behavioral outcomes induced by repetitive blast trauma.
Lee SJ; Logsdon AF; Yagi M; Baskin BM; Peskind ER; Raskind MM; Cook DG; Schindler AG
J Neuroinflammation; 2022 Dec; 19(1):288. PubMed ID: 36463243
[TBL] [Abstract][Full Text] [Related]
9. Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.
Anderson RI; Becker HC
Alcohol Clin Exp Res; 2017 Aug; 41(8):1402-1418. PubMed ID: 28425121
[TBL] [Abstract][Full Text] [Related]
10. The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.
Bruchas MR; Land BB; Chavkin C
Brain Res; 2010 Feb; 1314():44-55. PubMed ID: 19716811
[TBL] [Abstract][Full Text] [Related]
11. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.
Land BB; Bruchas MR; Lemos JC; Xu M; Melief EJ; Chavkin C
J Neurosci; 2008 Jan; 28(2):407-14. PubMed ID: 18184783
[TBL] [Abstract][Full Text] [Related]
12. Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.
Nygard SK; Hourguettes NJ; Sobczak GG; Carlezon WA; Bruchas MR
J Neurosci; 2016 Sep; 36(38):9937-48. PubMed ID: 27656031
[TBL] [Abstract][Full Text] [Related]
13. Dynorphin/Kappa-Opioid Receptor System Modulation of Cortical Circuitry.
Tejeda HA; Wang H; Flores RJ; Yarur HE
Handb Exp Pharmacol; 2022; 271():223-253. PubMed ID: 33580392
[TBL] [Abstract][Full Text] [Related]
14. Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders.
Tejeda HA; Bonci A
Brain Res; 2019 Jun; 1713():91-101. PubMed ID: 30244022
[TBL] [Abstract][Full Text] [Related]
15. Traumatic Brain Injury and Receipt of Prescription Opioid Therapy for Chronic Pain in Iraq and Afghanistan Veterans: Do Clinical Practice Guidelines Matter?
Seal KH; Bertenthal D; Barnes DE; Byers AL; Gibson CJ; Rife TL; Yaffe K;
J Pain; 2018 Aug; 19(8):931-941. PubMed ID: 29597083
[TBL] [Abstract][Full Text] [Related]
16. Dynorphin A, kappa opioid receptors and the antinociceptive efficacy of asimadoline in streptozotocin-induced diabetic rats.
Jolivalt CG; Jiang Y; Freshwater JD; Bartoszyk GD; Calcutt NA
Diabetologia; 2006 Nov; 49(11):2775-85. PubMed ID: 16924480
[TBL] [Abstract][Full Text] [Related]
17. Imaging Kappa Opioid Receptors in the Living Brain with Positron Emission Tomography.
Placzek MS
Handb Exp Pharmacol; 2022; 271():547-577. PubMed ID: 34363128
[TBL] [Abstract][Full Text] [Related]
18. Dynorphin and its role in alcohol use disorder.
Karkhanis AN; Al-Hasani R
Brain Res; 2020 May; 1735():146742. PubMed ID: 32114059
[TBL] [Abstract][Full Text] [Related]
19. Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance.
Xu M; Petraschka M; McLaughlin JP; Westenbroek RE; Caron MG; Lefkowitz RJ; Czyzyk TA; Pintar JE; Terman GW; Chavkin C
J Neurosci; 2004 May; 24(19):4576-84. PubMed ID: 15140929
[TBL] [Abstract][Full Text] [Related]
20. Big dynorphin as a putative endogenous ligand for the kappa-opioid receptor.
Merg F; Filliol D; Usynin I; Bazov I; Bark N; Hurd YL; Yakovleva T; Kieffer BL; Bakalkin G
J Neurochem; 2006 Apr; 97(1):292-301. PubMed ID: 16515546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
